|
|
||||||||
Cardiovascular Research Laboratory, Departments of Physiology and Medicine, University of California Los Angeles School of Medicine, Los Angeles, California 90095-1760
| |
ABSTRACT |
|---|
|
|
|---|
The purpose of this study was to determine
mitochondrial Ca2+ accumulation
and its possible role in initiation of mitochondrial permeability
transition (MPT) and sarcolemmal damage in
Ca2+-overloaded cardiomyocytes.
Cellular Ca2+ overload, generated
secondary to ouabain or
p-chloromercuribenzoate-stimulated cell Na+ concentration increase,
induced Ca2+ accumulation in
mitochondria (~3/4 of total net uptake) as identified by
kinetic analysis and verified by use of mitochondrial inhibition. Mitochondrial Ca2+ uptake was
followed by a rapid Ca2+ efflux
(~1 mmol · kg dry
wt
1 · min
1)
that can be best explained by efflux via
Ca2+-dependent nonspecific pores.
Cell ATP concentration was stable during mitochondrial
Ca2+ uptake and decreased in
parallel with Ca2+ efflux. In
addition, sarcolemmal damage was not related to the increase in
mitochondrial Ca2+ concentration
per se, but rather connected with the extent of Ca2+ efflux from the mitochondria.
A decrease in the rate of this Ca2+ efflux, indicating also a
decrease in a subpopulation of mitochondria with open pores, was
followed by decreased sarcolemmal damage. Both dithiothreitol and
cyclosporin A decreased rapid Ca2+
efflux and inhibited sarcolemmal damage, implicating MPT as an important component in the mechanism of sarcolemmal damage.
mitochondrial permeability transition; cyclosporin A; sulfhydryl groups
| |
INTRODUCTION |
|---|
|
|
|---|
ALTHOUGH NUMEROUS STUDIES suggest that cellular Ca2+ overload is responsible for irreversible myocardial injury in ischemia/reperfusion or hypoxia/reoxygenation, it remains unclear how Ca2+ mediates cell injury (34). One frequently proposed mechanism for transition from reversible to irreversible injury implicates mitochondrial Ca2+ overload with a subsequent Ca2+-dependent increase in mitochondrial inner membrane permeability. This is characterized by loss of mitochondrial membrane potential and equilibration of all solutes under 1,500 Da across the inner membrane (for reviews see Refs. 9 and 16). Mitochondrial matrix Ca2+ concentration ([Ca2+]) increase and interaction with poorly defined binding sites on the matrix side of the inner membrane is a specific and almost absolute requirement (one known exception is the phenylarsine oxide effect) for this megachannel opening, also termed mitochondrial permeability transition (MPT; see Ref. 16). It seems likely that, in cardiac cells during reperfusion/reoxygenation, MPT is initiated by Ca2+ in conjunction with another agent(s) called Ca2+-releasing or -inducing agent(s). In vitro experiments have generated a long list of transition-inducing agents, including various oxidizing and sulfhydril reagents (16). An increasing number of publications suggest that MPT is strongly regulated by oxidation/reduction of mitochondrial thiols (5, 19, 37). This type of regulation could be operative in cardiac cells, keeping in mind that reperfusion/reoxygenation is known to produce a burst of reactive oxygen species (9) generated in mitochondria during resumption of mitochondrial respiration upon reperfusion (2, 29). Reactive oxygen species are likely to act via oxidation of mitochondrial sulfhydryl groups (SH groups) responsible for modulation of MPT (5, 19, 37). In addition, depletion of mitochondrial antioxidants such as glutathione and NADPH also favors MPT (10, 33). Additional support in favor of the key role of MPT in reperfusion/reoxygenation injury comes from experiments on intact cells or isolated heart. These experiments have demonstrated that reperfusion/reoxygenation results in net Ca2+ uptake by myocardial cells, contractile dysfunction, sarcolemmal (SL) damage and cell death that are reduced or prevented with inhibition of mitochondrial electron transport (13, 36), and mitochondrial Ca2+ uptake via the uniporter with ruthenium red (1, 24, 36). Net Ca2+ uptake is associated with an increase in mitochondrial total (12) and free [Ca2+] (1, 24, 25), but not with additional increase in cytoplasmic [Ca2+] as found during ischemia (24) or hypoxia (25, 32). In addition, the time course of translocation of [3H]deoxyglucose into mitochondria suggests that nonspecific pores are closed during ischemia and open upon reperfusion (15). Cyclosporin A (CSA), which is the most potent inhibitor of MPT currently available, has been shown to partially protect the heart during reperfusion by improving postischemic function (14, 15). However, despite a reasonable correlation between the factors required for MPT in isolated mitochondria and those thought to be responsible for ischemia/reperfusion injury, the role of Ca2+-dependent MPT in the development of SL damage has not been investigated in cardiac cells. In Ca2+-overloaded cardiomyocytes, mitochondria are expected to accumulate and buffer large amounts of Ca2+ before matrix free [Ca2+] reaches the level required to open nonspecific pores and release Ca2+ into the cytoplasm. If the pore opening, as manifested by rapid Ca2+ efflux and sensitivity to CSA, is related to SL damage, then an increase or decrease in a subpopulation of mitochondria with open pores should correspondingly accelerate or slow down SL permeability increase. To test this hypothesis, we developed a technique that allows monitoring of mitochondrial Ca2+ uptake/efflux and relation of these changes to SL damage in Ca2+-overloaded cardiomyocytes. Selective inhibition of Na+-K+-ATPase allowed us to generate myoplasmic Ca2+ overload, secondary to intracellular Na+ concentration ([Na+]i) increase via Na+/Ca2+ exchange, that was significantly buffered by mitochondrial Ca2+ accumulation. During the time of Ca2+ accumulation, cellular ATP concentration ([ATP]) was stable but started to decrease when MPT was induced in a large subpopulation of Ca2+-overloaded mitochondria. MPT, as characterized by rapid Ca2+ efflux and its sensitivity to CSA and dithiothreitol (DTT), was followed by SL damage. Manipulations directed to closure of nonspecific pores significantly decreased SL damage.
| |
METHODS |
|---|
|
|
|---|
Cell culture. Hearts were obtained from neonatal Sprague-Dawley rats (1-2 days old), and cells were isolated as described (30). Depending on the experimental protocol, cells were plated on Falcon dishes, on slides cut from Primaria dishes, on coverslips, or on plastic disks containing scintillant. Cells were used after 3-4 days in primary culture.
The standard perfusate was HEPES-based buffer containing (in mM) 5 HEPES, pH 7.3 (at 37°C), 138 NaCl, 3.6 KCl, 0.3 MgCl2, 1 CaCl2, and 16 glucose. Ouabain and
DTT were directly added and dissolved in superfusion or incubation
buffer. pH was corrected with NaOH after DTT addition. Because of the
limited solubility of
p-chloromercuribenzoate (pCMB) at pH
7.3, it was dissolved at alkaline pH, and pH was adjusted to 7.3 after
addition of pCMB to the buffer. CSA and carbonyl cyanide
p-trifluoromethoxyphenyl-hydrazone (FCCP) were dissolved in dimethyl sulfoxide (DMSO). When added to the
buffer, DMSO concentration was 0.05% (vol/vol). Net
Ca2+ uptake,
Ca2+ content in the mitochondrial
compartment,
Na+/Ca2+
exchange-mediated Ca2+ efflux, and
[Na+]i
were measured in thermostated boxes at 37°C. Lactate and lactate dehydrogenase (LDH) release from the cells was determined in a shaking
water bath at 37°C. Extracellular buffer volume was 2-3 ml in
these experiments. Oxygen content of the buffer was sufficient to avoid
any significant increase in lactate production during spontaneous
beating of cells, as demonstrated by the stable lactate concentration
([lactate]) level in the extracellular buffer. Basal rate
of lactate production was 15 ± 8 nmol · mg
protein
1 · min
1
(n = 7). However, inhibition of
mitochondrial electron transport with 3 mM NaCN increased lactate
production >15-fold in 5 min. [Lactate] was determined by
NAD reduction in the presence of 15 units LDH after 90 min of
incubation at room temperature (4).
Net Ca2+ uptake by the cells was monitored by the scintillation flow cell (chamber volume 7 ml) technique described previously in detail (21). The system allows continuous, on-line recording of cellular 45Ca2+ activity with rapid change in the perfusion medium at any selected time over a period of hours in intact functional cells. The cells, cultured on scintillant-containing disks, were mounted in a flow cell and perfused with HEPES buffer at a rate of 10 ml/min. Next, the cells were asymptotically labeled with 45Ca2+ (1 mCi/mmol Ca2+) and then exposed to ouabain or pCMB. Under those conditions, any change in the 45Ca2+ signal away from the established baseline is due to net changes in cellular calcium. At the end of the experiment, dry weight of the cells and specific activity of the perfusate were determined. Changes in cell-associated Ca2+ with respect to the control asymptotic value were expressed as millimoles per kilogram of dry weight.
Ca2+ uptake by the mitochondrial compartment was determined by kinetic analysis, described in detail previously (20), or by subtracting the fraction of Ca2+ uptake inhibited or released with FCCP from the net Ca2+ uptake in the absence of FCCP. It had been previously documented that the kinetically defined "slow" compartment in these cells represents mitochondrial Ca2+ exchange (21). For kinetic analysis, the cells were labeled with 45Ca2+ (30 µCi/µmol Ca2+) in the flow cell for 35 min at 37°C. Washout was performed with HEPES buffer at a flow rate of 26 ml/min (not rate limiting for mitochondrial exchange) for at least 60 min. After the first washout, which served as a control, the same cells were labeled with 45Ca2+ for 10-15 min. Cells were then exposed to 250 µM pCMB or 1 mM ouabain, and Ca2+ uptake was continuously monitored. Washout was started when Ca2+ uptake had reached plateau. The monoexponential part of the washout curve between 30 and 60 min was fitted and extrapolated to time 0. The time 0 intercept of this kinetically defined slow compartment has been demonstrated to represent the 45Ca2+ content in the mitochondrial compartment (20). Measurement of the total net cellular Ca2+ uptake compared with that from the prior 45Ca2+ labeling permitted calculation of the change in mitochondrial uptake associated with the experimental intervention.
Na+/Ca2+ exchange-mediated 45Ca2+ efflux was determined as described in detail (39). Cells grown on a slide cut from a Primaria dish were labeled with 45Ca2+ (30 µCi/µmol Ca2+) for 35 min at 37°C. After this incubation, cells were superfused first with 0 Na+, 0 Ca2+ HEPES buffer (pH 7.3 adjusted with Tris, NaCl replaced with choline chloride) for 40 s. Na+ and Ca2+ were returned to the perfusate at the 41st s, and perfusion was continued for another 40 s. A microcomputer delivered perfusate at a rate 3 ml/s in separate pulses. These pulses were collected in separate vials for scintillation counting. When Na+ and Ca2+ were returned and Na+/Ca2+ exchange "turned on," a clearly defined increase in 45Ca2+ activity is recorded in the effluent (see Fig. 4). Integration of this transient increase in 45Ca2+ gives a measurement of Ca2+ efflux specifically dependent on Na+/Ca2+ exchange (39).
Cytosolic free Na+ concentration ([Na+]) was measured with the use of sodium-binding benzofuran isophthalate (SBFI) as described (11) with some modifications. Cells were loaded with the AM ester of SBFI for 1.5 h at 37°C. Final concentrations for SBFI and Pluronic F-127 in the loading solution were 15 µM and 0.4% correspondingly. Excitation light was provided at 340 and 380 nm, and fluorescence was measured at 510 nm. In vivo calibration of the SBFI fluorescence 340/380 ratio (F340/F380) was performed by exposing the cells to various [Na+] in calibration buffer (Na+ + K+ = 150 mM, 5 mM HEPES, pH 7.3, 20 µM gramicidin D, 40 µM monensin, 1 µM FCCP, and 1 mM iodoacetic acid). In these experiments, the F340/F380 ratio increases in parallel with increasing [Na+] up to 50 mM.
Tissue [ATP] was determined by the firefly luciferase method (Bioluminescent somatic cell assay kit; Sigma) following the manufacturer's instruction. Cells were washed with ice-cold buffer and treated with 200 µl of cell-releasing reagent on ice. This suspension was quickly diluted with 400 µl H2O, and 20 µl were used to measure light emission with a liquid scintillation spectrometer.
LDH activity was determined as described (30) by oxidation of NADH in potassium phosphate buffer (pH 7.65) containing sodium pyruvate and NADH. LDH release during metabolic inhibition was evaluated relative to the total cellular LDH content.
Cellular protein content was determined by the method of Lowry et al. (23).
SBFI and Pluronic F-127 20% solution in DMSO were from Molecular Probes (Eugene, OR). All other reagents were from Sigma.
Data are presented as means ± SD in Figs. 1-7 or as representative tracings with indication of the number of experiments. For differences between mean values, Student's t-test was used. A P value <0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Cellular Ca2+ overload was generated by Na+ pump inhibition using ouabain or pCMB to increase cellular [Na+] and activate "reverse" Na+/Ca2+ exchange to induce cellular Ca2+ overload. Ouabain specifically inhibits Na+-K+-ATPase and Na+ transport out of cells that results in Na+ accumulation. pCMB, a specific sulfhydryl group reagent (38), also inhibits Na+-K+-ATPase activity by blocking functionally important SH groups (18). This is demonstrated in Fig. 1 in which cells exposed to 250 µM pCMB rapidly accumulated Na+. Inhibition of Na+-K+-ATPase with 1 mM ouabain (Fig. 2A) or 250 µM pCMB (Fig. 2B) resulted in a significant net Ca2+ uptake that was followed by net Ca2+ efflux. An increase in pCMB concentration ([pCMB]) accelerated net Ca2+ uptake and also subsequent Ca2+ efflux, but in the range of 250-600 µM [pCMB] had no significant effect on the total amount of accumulated Ca2+ (Fig. 2C). For reasons that are not totally clear, Ca2+ uptake in ouabain-treated cells started after a lag period that was very variable (37 ± 16.8 min, n = 15). However, once started, Ca2+ uptake was always much higher compared with pCMB-treated cells.
|
|
We have also evaluated the effect of 0 K+ perfusion and membrane-impermeable p-chloromercuriphenylsulfonic acid (pCMPSA), both known to inhibit Na+-K+-ATPase. Both treatments induced significant cellular Ca2+ uptake that was followed by Ca2+ efflux (data not presented). Experiments with pCMPSA also showed that at least some of the functionally important SH groups of Na+-K+-ATPase protein, which spans the cell membrane, are exposed to the extracellular environment. SH group location on the extracellular face of Na+-K+-ATPase has been demonstrated by recording the effect of selective application of pCMPSA on Na+-K+ pump current in guinea pig ventricular myocytes (17), and this location also explains the rapid effect of pCMB (Fig. 1).
To determine mitochondrial Ca2+
accumulation that, in the case of normal, functional mitochondria is
expected to follow and buffer cytoplasmic
Ca2+ overload, we used FCCP as a
probe in addition to kinetic analysis. FCCP is expected to collapse the
proton electrochemical gradient across the mitochondrial inner
membrane, which is the driving force for
Ca2+ uptake via the uniporter.
This reduces the gradient of mitochondrial Ca2+ to
cytoplasmic Ca2+ to unity. Exposure of cells to FCCP before
either ouabain or pCMB were added significantly inhibited net
Ca2+ uptake and totally eliminated
the late Ca2+ efflux (Fig. 2,
A and
B). In the absence of FCCP, net
Ca2+ efflux in ouabain and
pCMB-treated cells continued to the level approximately corresponding
to the net Ca2+ uptake in the
presence of FCCP. However, in ouabain-treated cells, the rate of
Ca2+ efflux was rapid (~1
mmol · kg
1 · min
1)
initially and then decreased, reaching the level recorded in the
presence of FCCP after a time period >60 min (Fig.
2A). The finding that net
Ca2+ efflux can be accelerated by
exposing cells to FCCP after cellular net
Ca2+ uptake has reached plateau
(compare Fig. 2, B and
C, trace labeled 250 µM) and
cellular [Ca2+]
decreases to the level reached in pCMB-treated cells in the presence of
FCCP (Fig. 2B) suggests that ~75%
of net Ca2+ efflux is due to
mitochondrial Ca2+ efflux.
Ca2+ uptake by respiring mitochondria was also quantified by kinetic analysis. By monitoring the slow component of cellular 45Ca2+ exchange, demonstrated to reflect mitochondrial [Ca2+] (20, 21), we can show that, in ouabain-treated cells, ~80% of the total cellular 45Ca2+ content was coming out slowly, with a half-time of 28 min, which is characteristic of the Ca2+ efflux from the mitochondrial compartment (Fig. 3A). In this experiment, cellular net Ca2+ uptake was 73 mmol/kg dry wt. As expected, kinetic analysis revealed less mitochondrial Ca2+ accumulation in pCMB-treated cells (Fig. 3B). However, the values (between 50 and 60%) still indicate significant Ca2+ accumulation in the mitochondrial compartment.
|
Ca2+ released from the mitochondria into the cytoplasm is removed from the cell via Na+/Ca2+ exchange according to the thermodynamic equilibrium determined by Na+ and Ca2+ transmembrane gradients and membrane potential. In this connection, it is important to demonstrate that pCMB treatment had no significant depressive effect on SL Na+/Ca2+ exchanger function. The results presented in Fig. 4 show that this is the case. First, we demonstrate that the amount of 45Ca2+ removed from the cells via Na+/Ca2+ exchange during the first and second washout is reproducible under the same experimental conditions (Fig. 4A) and that 5 mM Ni2+ almost totally inhibited Na+/Ca2+ exchange (Fig. 4B). This result affirms that Na+-Ca2+-dependent 45Ca2+ efflux can be used as an indicator of Na+/Ca2+ exchange activity in intact cells under these conditions. Cells exposed to pCMB during 35 min incubation with 45Ca2+ demonstrated much higher 45Ca2+ efflux compared with control during 0 Na+, 0 Ca2+ superfusion (Fig. 4C). This finding also means that Na+/Ca2+ exchange-dependent 45Ca2+ efflux started at a significantly higher level, which makes it difficult to compare 45Ca2+ transients in the control and pCMB-treated cells. In addition, in Ca2+-overloaded cells, Na+/Ca2+ exchange-mediated 45Ca2+ efflux did not return to the baseline level characteristic of control but remained significantly higher for the duration of the washout (Fig. 4C). This finding indicates that cellular 45Ca2+ is continuously transported out of the cell via the Na+/Ca2+ exchanger in increased quantity. The high level of 45Ca2+ efflux in 0 Na+, 0 Ca2+ solution (initial 40 s) most likely represents residual operation of the exchanger in the Ca2+/Ca2+ exchange mode (35) due to the known presence of contaminant Ca2+ (~10 µM) in the "0" Ca2+ solution. This is supported by the effect of EGTA on this component of the 45Ca2+ washout (Fig. 4D). In these experiments, the 45Ca2+ transient in pCMB-treated cells was significantly higher than that in controls, reflecting the functional response of the exchanger to increased intracellular [Ca2+]. The average integrated Na+/Ca2+ exchange-mediated Ca2+ transient of 43,531 ± 7,412 counts per minute (cpm) (n = 3) under control conditions is significantly less than the transient in the same cells treated with pCMB (153,323 ± 16,572 cpm, n = 3).
|
Having established the extent of mitochondrial
Ca2+ uptake in cardiomyocytes by
using FCCP and kinetic analysis, we next examined the route of
mitochondrial net Ca2+ efflux,
which followed Ca2+ uptake as
shown in Fig. 2. Three mechanisms exist for mitochondrial Ca2+ efflux:
Na+-independent efflux,
Na+-dependent efflux, and efflux
via nonspecific pores (16). The first two require energy, and in heart
mitochondria the Na+-dependent
Ca2+ efflux mechanism via
Na+/Ca2+
exchange dominates under physiological conditions, but its maximum velocity is roughly two orders of magnitude lower than
Ca2+ uptake via the uniporter
(16). In our experiments, Ca2+
efflux rates were only slightly lower than
Ca2+ uptake rates via the
uniporter. The rate of Ca2+ efflux
in pCMB (250 µM)-treated cells was 1.34 ± 0.28 and that of
Ca2+ uptake was 2.6 ± 0.34 mmol · kg dry
wt
1 · min
1
(n = 9). In ouabain-treated cells, the
initial rate of Ca2+ efflux was
also high (1.2 ± 0.4 mmol · kg dry
wt
1 · min
1,
n = 5). In addition, diltiazem (500 µM), which is expected to partially inhibit mitochondrial
Na+/Ca2+
exchange (8), had no effect on
Ca2+ efflux (data not presented).
Ruthenium red (3 µM), added at the peak of pCMB-stimulated
Ca2+ uptake, didn't inhibit
Ca2+ efflux, ruling out
Ca2+ efflux via reverse uniporter
(data not presented). Therefore, it is most likely that the rapid
Ca2+ efflux is due to the opening
of nonspecific pores triggered by an increase in matrix
[Ca2+]. In
pCMB-treated cells, sustained, rapid
Ca2+ efflux suggests that MPT was
initiated in a large subpopulation of mitochondria so that released
Ca2+ reuptake by still impermeable
mitochondria was not significant during
Ca2+ efflux, whereas in
ouabain-treated cells this reuptake could play a significant role in
changing the Ca2+ efflux kinetics
(Fig. 2A).
An important question emerging from these observations is the relationship between MPT, as manifested by rapid Ca2+ efflux and SL damage resulting in cell death. Results presented in Fig. 5 show that SL damage is not related to the extent of Ca2+ uptake but rather to the rate of Ca2+ efflux. Clearly, mitochondrial Ca2+ uptake in ouabain-treated cells was high, but Ca2+ efflux, particularly in its late phase, was relatively slow (Fig. 2A), and SL damage, as demonstrated by LDH release, developed relatively slowly compared with the effect of pCMB (Fig. 5). Furthermore, LDH release was initiated close to the point where Ca2+ efflux is completed in pCMB-treated cells (compare Figs. 2C and 5). To investigate whether the pore opening, as monitored by the rapid mitochondrial Ca2+ efflux, is related to plasma membrane damage, we used DTT and CSA, which are expected to inhibit MPT via different mechanisms. Addition of DTT (5 mM) to pCMB-treated cells after they had been incubated with 250 µM pCMB for 30 min, i.e., at the time point where Ca2+ accumulation was close to maximum (Fig. 2, B and C), drastically inhibited LDH release. However, because the effect of DTT in pCMB-treated cells could be also connected with partial reactivation of Na+-K+-ATPase, this experiment was repeated with ouabain-treated cells. First, DTT, added at the plateau of ouabain-stimulated Ca2+ uptake, slightly stimulated uptake and completely inhibited Ca2+ efflux. However, this effect was transient, lasting ~1 h, and was followed by Ca2+ efflux with a rate characteristic to pore opening in a large subpopulation of mitochondria (Fig. 6A). In accordance with this finding, LDH release was delayed but not totally avoided by DTT (data not shown). When cells were exposed to CSA instead of DTT, Ca2+ efflux was inhibited but not completely avoided. Because high cytoplasmic [Na+] and mitochondrial [Ca2+] are expected to stimulate mitochondrial Ca2+ efflux via Na+/Ca2+ exchange, diltiazem was used to inhibit this route of efflux. From Fig. 6A, it is evident that 500 µM diltiazem and 5 µM CSA are unable to block slow Ca2+ efflux, but fast Ca2+ efflux, seen in ouabain plus DTT-treated cells after a lag period, was avoided. Because diltiazem is not a very potent inhibitor of mitochondrial Na+/Ca2+ exchange (8), some Ca2+ efflux via this route may still take place. Most importantly, SL damage can be significantly reduced by adding 5 µM CSA to ouabain-treated cells at the time point when, in the majority of experiments, mitochondrial Ca2+ accumulation had reached a level close to maximum (Fig. 6B). Different from these findings, CSA (0.2-5.0 µM) added at the plateau of pCMB-stimulated Ca2+ uptake had no significant effect on Ca2+ efflux (data not shown).
|
|
The data presented above indicate that Na+-K+-ATPase inhibition and cellular [Na+] increase initiated the following sequence of events: reverse Na+/Ca2+ exchange leading to myoplasmic [Ca2+] increase that is buffered by mitochondrial Ca2+ uptake up to the level where Ca2+-dependent MPT is induced and mitochondria release the accumulated Ca2+. Because SL damage appears to be related to the permeability transition, it was important to test the energy state of the cell before and after mitochondrial Ca2+ overload induced pore opening and Ca2+ efflux. For that reason, cellular [ATP] was followed in parallel with that of net Ca2+ uptake and efflux in pCMB-treated cells (Fig. 7). No significant change in [ATP] was observed during cellular (mitochondrial) Ca2+ uptake, suggesting that this uptake is not induced by metabolic changes other than Na+ pump inhibition. However, the [ATP] decrease started at about the time when Ca2+ efflux was initiated and [ATP] then decreased in parallel with mitochondrial Ca2+ efflux.
|
| |
DISCUSSION |
|---|
|
|
|---|
Recent experiments have indicated that reperfusion/reoxygenation injury correlates well with mitochondrial Ca2+ uptake, although there is no correlation with cytoplasmic [Ca2+] (24, 25). These results combined with those presented briefly in the introduction are all consistent with Ca2+-dependent MPT playing an important role in the damage that occurs during reperfusion. Mitochondrial matrix [Ca2+] required to promote MPT is not exactly known but, in the absence of an inductor, concentrations >100 µM are required to trigger the transition in isolated mitochondria (16). By measuring the rate of passive osmotic contraction of isolated heart mitochondria in response to polyethylene glycol (considered to be proportional to the number of open pores), the apparent Michaelis constant for Ca2+ was found to be ~15 µM. A Hill's plot suggests the presence of at least two cooperative binding sites for Ca2+ (26). This requirement for high [Ca2+] is not unexpected, because mitochondria can accumulate total Ca2+ several orders of magnitude more than free [Ca2+] (~1 µM; see Refs. 24 and 25) with >99% of mitochondrial Ca2+ bound to multiple binding sites. Mitochondrial matrix buffers Ca2+ quickly and reversibly with an effective binding ratio of 4,000, which is 40 times the Ca2+ binding ratio of the cytoplasm (3). For that reason, any mitochondrial Ca2+ uptake or release will simply result in a new equilibrium between bound and free Ca2+, and actual changes in mitochondrial free [Ca2+] are expected to be relatively small. The finding that significant mitochondrial Ca2+ accumulation is required to initiate MPT in ouabain-treated cells also indicates a low Ca2+ binding affinity of MPT-related sites. This allows the majority of intramitochondrial binding sites to be saturated before matrix free [Ca2+] reaches the level required to initiate MPT. However, the requirement for matrix Ca2+ can be modulated by several factors, meaning that pore opening is also possible at very low matrix [Ca2+] (28). In the first part of our study, we propose a method for monitoring mitochondrial Ca2+ uptake and efflux in intact cardiomyocytes. Although we recorded net cellular Ca2+ uptake and efflux, an increase in cytoplasmic [Ca2+] due to mitochondrial Ca2+ efflux is expected to result in Ca2+ efflux via the SL Na+/Ca2+ exchanger. This has been demonstrated to be the case in our experimental model. There seems to be a gradual increase in mitochondrial Ca2+ efflux during pCMB-stimulated Ca2+ uptake. This would explain 1) significantly higher mito- chondrial Ca2+ uptake in ouabain-treated cells; 2) the finding that the [pCMB] increase from 250 to 600 µM enhanced the rate of Ca2+ accumulation and efflux, but had no significant effect on the amount of accumulated Ca2+ (Fig. 2C); and 3) stimulation of Ca2+ uptake with DTT after Ca2+ uptake had ceased (results not shown). In general, SH group reagents are known to induce MPT (16), but pCMB penetration through the membranes is expected to be slow due to its poor lipophilicity, as indicated by the octanol/water distribution coefficient of 0.03 (18). That is expected to delay the pCMB effect on mitochondrial SH groups, and therefore mitochondria would be expected to accumulate significant amounts of Ca2+ before a preponderance of Ca2+-permeable mitochondria produces net Ca2+ efflux. It should be noted that experiments with DTT are complicated by the ability of DTT to reactivate Na+-K+-ATPase, as demonstrated by intracellular Na+ decrease (P. Korge, unpublished results). This recovery of transmembrane Na+ gradient results in Ca2+ efflux via SL Na+/Ca2+ exchange, which is expected to decrease membrane damage. However, support for the role of SH groups in the regulation of MPT in Ca2+-overloaded cells comes from ouabain-treated cells in which DTT is not expected to reactivate Na+-K+-ATPase. A transient but significant inhibitory effect of DTT on Ca2+ efflux and LDH release in ouabain-treated cells could be connected with reduction of SH groups oxidized by reactive oxygen species produced by the respiratory chain. In fact, ouabain-induced Ca2+ overload has been demonstrated to generate reactive oxygen species in rat ventricle (27). Furthermore, exogenous catalase (37) or butylhydroxytoluene (7) effectively reduced Ca2+-dependent MPT generated in the absence of oxidizing or SH group reagents in isolated respiring mitochondria. In ouabain-treated cells, mitochondrial Ca2+ efflux started at a significantly higher level of mitochondrial [Ca2+], and the rate of efflux was slower compared with pCMB-treated cells. This finding is not unexpected because experiments with isolated heart mitochondria have demonstrated that, in the absence of oxidant, high [Ca2+] (150 µM) was required to initiate MPT, but oxidant (cumen hydroperoxide) drastically accelerated the MPT even in the presence of relatively low matrix [Ca2+] (26). Mitochondrial inhomogeneity, i.e., simultaneous existence of permeable and impermeable fractions, together with slow Ca2+ efflux via the Na+-dependent pathway obviously complicate the interpretation of MPT based on Ca2+ efflux. However, the ability of 5 µM CSA to effectively prevent SL damage in ouabain-treated cells strongly suggests that significant mitochondrial Ca2+ accumulation resulted in pore opening that directly or indirectly was related to SL damage. The reason why mitochondrial Ca2+ efflux was not significantly inhibited with CSA in the presence of pCMB remains to be determined. CSA is a potent inhibitor of MPT, but its inhibitory activity in isolated mitochondria could be transient and is not always observed (6). The factors involved in promoting pore opening when CSA is present are not fully understood, but high matrix [Ca2+] (15, 26), loss of matrix ADP, ATP, and Mg2+ (15, 26), free fatty acid accumulation, or production of small amounts of amphipathic peptides by proteases in the matrix space (6) could be involved. In fact, these conditions may occur during the initial phase of reperfusion and may well explain why CSA did not inhibit MPT, as evaluated by mitochondrial [3H]deoxyglucose uptake in reperfused hearts (15). As stated above, pore opening is regulated by the redox state of mitochondrial SH groups, and the presence of oxidants or SH group reagents can significantly decrease or abolish the effect of CSA (6, 26).
As an important consequence of pore opening, cytoplasmic ATP can gain access to mitochondrial ATPase. In our experiments cellular [ATP] was depleted essentially in parallel with Ca2+ efflux in pCMB-treated cells. To prevent an increase in entropy and cell death, a certain level of ATP regeneration is required, but a correlation between ATP depletion, MPT, and cell death is not always observed. Experimental evidence suggests that cell death could be related to MPT by a mechanism that is independent of mitochondrial membrane potential and ATP depletion (28).
Because this study was directed to investigate the importance of Ca2+-dependent MPT in SL damage, it was mandatory to follow mitochondrial Ca2+ uptake and efflux in the intact, functional cell. This requirement also puts certain limitations on our study, but the results clearly demonstrate that interaction between mitochondrial Ca2+ movements and their effect on SL permeability can be investigated in intact cells. Under these conditions, monitoring of mitochondrial Ca2+ uptake and rapid efflux is likely to be the most sensitive indicator of MPT, whereas CSA offers the most specific probe to investigate the involvement of MPT in SL damage. The results demonstrate the sequence of ionic fluxes leading to mitochondrial Ca2+ overload during the period when ATP resynthesis was not compromised. These initial events were followed by permeability transition, characterized by rapid and significant Ca2+ efflux into the cytoplasm and ATP decrease. Irreversible damage, as manifested by a significant increase in LDH leakage (Fig. 5), started after mitochondrial Ca2+ efflux had essentially ceased and [ATP] had reached a level ~10% of the initial value (Fig. 7). Although the cause of Ca2+ overload-induced injury is apparently multifactorial, we believe that an important component of SL damage is initiated by mitochondrial Ca2+ efflux, which rapidly generates significant cytoplasmic [Ca2+] overload. The last then could lead to destabilization of SL phospholipid and onset of enzyme leakage (31).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Eloise Farley for superb technical assistance.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-28539-11 and the Laubisch and Castera Endowments.
Address for reprint requests: P. Korge, Cardiovascular Research Laboratories, UCLA School of Medicine, MRL Bldg., 675 Circle Drive South, Rm. 3645, Los Angeles, CA 90095-1760.
Received 25 November 1997; accepted in final form 4 March 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Allen, S. P.,
V. M. Darley-Usmar,
J. G. McCormack,
and
D. Stone.
Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reoxygenation.
J. Mol. Cell. Cardiol.
25:
949-958,
1993[Medline].
2.
Ambrosio, G.,
J. L. Zweier,
C. Duilio,
P. Kuppusamy,
G. Santoro,
P. P. Elia,
I. Tritto,
P. Cirillo,
M. Condorelli,
M. Chiariello,
and
J. T. Flaherty.
Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow.
J. Biol. Chem.
268:
18532-18541,
1993
3.
Babcock, D. F.,
J. Herrington,
P. C. Goodwin,
Y. B. Park,
and
B. Hille.
Mitochondrial participation in the intracellular Ca2+ network.
J. Cell Biol.
136:
833-844,
1997
4.
Bergmeyer, H. U.
Methods in Enzymatic Analysis. New York: Academic, 1974, vol. 2.
5.
Bernardi, P.,
K. M. Broekemeier,
and
D. R. Pfeiffer.
Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane.
J. Bioenerg. Biomembr.
26:
509-517,
1994[Medline].
6.
Broekemeier, K. M.,
and
D. R. Pfeiffer.
Inhibition of mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases.
Biochemistry
34:
16440-16449,
1995[Medline].
7.
Carbonera, D.,
and
G. F. Azzone.
Permeability of inner mitochondrial membrane and oxidative stress.
Biochim. Biophys. Acta
943:
245-255,
1988[Medline].
8.
Cox, D. A.,
and
M. A. Matlib.
A role for the mitochondrial Na+-Ca2+ exchanger in the regulation of oxidative phosphorylation in isolated heart mitochondria.
J. Biol. Chem.
268:
938-947,
1993
9.
Crompton, M.
The role of Ca2+ in the function and dysfunction of heart mitochondria.
In: Calcium and the Heart, edited by G. A. Langer. New York: Raven, 1990, p. 167-198.
10.
Dhanbhoora, C. M.,
and
J. R. Babson.
Thiol depletion induces lethal cell injury in cultured cardiomyocytes.
Arch. Biochem. Biophys.
293:
130-139,
1992[Medline].
11.
Donoso, P.,
J. G. Mill,
S. C. O'Neill,
and
D. A. Eisner.
Fluorescence measurements of cytoplasmic and mitochondrial sodium concentration in rat ventricular myocytes.
J. Physiol. Paris
448:
493-509,
1992.
12.
Ferrari, R.,
P. Pedersini,
M. Bongrazio,
G. Gaia,
P. Bernocchi,
F. Di Lisa,
and
O. Visioli.
Mitochondrial energy production and cation control in myocardial ischemia and reperfusion.
Basic Res. Cardiol.
88:
495-512,
1993[Medline].
13.
Ganote, C. E.,
J. Worstell,
and
J. P. Kaltenbach.
Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts.
Am. J. Pathol.
84:
327-350,
1976[Abstract].
14.
Griffiths, E. J.,
and
A. P. Halestrap.
Protection by cyclosporine A of ischemia/reperfusion-induced damage in isolated rat hearts.
J. Mol. Cell. Cardiol.
25:
1461-1469,
1993[Medline].
15.
Griffiths, E. J.,
and
A. P. Halestrap.
Mitochondrial non-specific pores remain closed during ischemia, but open upon reperfusion.
Biochem. J.
307:
93-98,
1995.
16.
Gunter, T. E.,
K. K. Gunter,
S.-S. Sheu,
and
C. E. Gavin.
Mitochondrial calcium transport: physiological and pathological relevance.
Am. J. Physiol.
267 (Cell Physiol. 36):
C313-C339,
1994
17.
Haddock, P. S.,
M. J. Shattock,
and
D. J. Hearse.
Modulation of cardiac Na+-K+ pump current: role of protein and nonprotein sulfhydril redox status.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H297-H307,
1995
18.
Halbach, S.,
G. Schonsteiner,
and
W. Vierling.
The action of organic mercury compounds on the function of isolated mammalian heart muscle.
Eur. J. Pharmacol.
167:
255-264,
1989[Medline].
19.
Halestrap, A. P.,
K.-Y. Woodfield,
and
C. P. Connern.
Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase.
J. Biol. Chem.
272:
3346-3354,
1997
20.
Kuwata, J. H.,
and
G. A. Langer.
Rapid, non-perfusion-limited calcium exchange in cultured neonatal myocardial cells.
J. Mol. Cell. Cardiol.
21:
1195-1208,
1989[Medline].
21.
Langer, G. A.,
and
L. M. Nudd.
Addition and kinetic characterization of mitochondrial calcium in myocardial tissue culture.
Am. J. Physiol.
239 (Heart Circ. Physiol. 8):
H769-H774,
1980.
22.
Langer, G. A.,
T. L. Rich,
and
F. B. Orner.
Ca exchange under non-perfusion-limited conditions in rat ventricular cells: identification of subcellular compartments.
Am. J. Physiol.
259 (Heart Circ. Physiol. 28):
H592-H602,
1990
23.
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr,
and
R. J. Randall.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:
265-275,
1951
24.
Miyamae, M.,
S. A. Camacho,
M. W. Weiner,
and
V. M. Figueredo.
Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat heart.
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H2145-H2153,
1996
25.
Miyata, H.,
E. G. Lakatta,
M. D. Stern,
and
H. S. Silverman.
Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia.
Circ. Res.
71:
605-613,
1992
26.
Novgorodov, S. A.,
T. I. Gudz,
Y. M. Milgrom,
and
G. P. Brierley.
The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A.
J. Biol. Chem.
267:
16274-16282,
1992
27.
Obata, T.,
M. Tamura,
and
Y. Yamanaka.
Evidence of hydroxyl free radical generation by calcium overload in rat myocardium.
J. Pharm. Pharmacol.
49:
787-790,
1997[Medline].
28.
Pastorino, J. G.,
J. W. Snyder,
J. B. Hoek,
and
J. L. Farber.
Ca2+ depletion prevents anoxic death of hepatocytes by inhibiting mitochondrial permeability transition.
Am. J. Physiol.
268 (Cell Physiol. 37):
C676-C685,
1995
29.
Piper, H. M.,
T. Noll,
and
B. Siegmund.
Mitochondrial function in oxygen depleted and reoxygenated myocardial cell.
Cardiovasc. Res.
28:
1-15,
1994
30.
Post, J. A.,
J. R. Clague,
and
G. A. Langer.
Sarcolemmal phospholipid asymmetry and Ca fluxes on metabolic inhibition of neonatal rat heart cells.
Am. J. Physiol.
265 (Heart Circ. Physiol. 34):
H461-H468,
1993
31.
Post, J. A.,
S.-Y. Wang,
and
G. A. Langer.
pHe, [Ca]e, and cell death during metabolic inhibition. Role of phospholipase A2 and sarcolemmal phospholipids.
Am. J. Physiol.
274 (Heart Circ. Physiol. 43):
H18-H26,
1998
32.
Quaife, R. A.,
O. Kohmoto,
and
W. H. Barry.
Mechanisms of reoxygenation injury in cultured ventricular myocytes.
Circulation
83:
566-577,
1991
33.
Reed, J. D.,
and
M. K. Savage.
Influence of metabolic inhibitors on mitochondrial permeability transition and glutathione status.
Biochim. Biophys. Acta
1271:
43-50,
1995[Medline].
34.
Silverman, H. S.,
and
M. D. Stern.
Ionic basis of ischemic cardiac injury: insights from cellular studies.
Cardiovasc. Res.
28:
581-597,
1994
35.
Slaughter, R. S.,
J. L. Sutko,
and
J. P. Reeves.
Equilibrium calcium-calcium exchange in cardiac sarcolemmal vesicles.
J. Biol. Chem.
258:
3183-3190,
1983
36.
Stone, D.,
V. Darley-Usmar,
D. R. Smith,
and
V. O'Leary.
Hypoxia-reoxygenation induced increase in cellular Ca2+ in myocytes and perfused hearts: the role of mitochondria.
J. Mol. Cell. Cardiol.
21:
963-973,
1989[Medline].
37.
Valle, V. G.,
M. M. Fagian,
L. S. Parentoni,
A. R. Meinicke,
and
A. E. Vercesi.
The participation of reactive oxygen species and protein thiols in the mechanism of mitochondrial inner membrane permeabilization by calcium plus prooxidants.
Arch. Biochem. Biophys.
307:
1-7,
1993[Medline].
38.
Van Iwaarden, P. R.,
A. J. M. Driessen,
and
W. N. Konings.
What we can learn from the effects of thiol reagents on transport proteins.
Biochim. Biophys. Acta
1113:
161-170,
1992[Medline].
39.
Wang, S-Y.,
A. Peskoff,
and
G. A. Langer.
Inner sarcolemmal leaflet Ca2+ binding: its role in cardiac Na/Ca exchange.
Biophys. J.
70:
2266-2274,
1996
This article has been cited by other articles:
![]() |
S. E. Anderson, H. Liu, H. S. Ho, E. J. Lewis, and P. M. Cala Age-related differences in Na+-dependent Ca2+ accumulation in rabbit hearts exposed to hypoxia and acidification Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1123 - C1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Korge, H. M. Honda, and J. N. Weiss Regulation of the mitochondrial permeability transition by matrix Ca2+ and voltage during anoxia/reoxygenation Am J Physiol Cell Physiol, March 1, 2001; 280(3): C517 - C526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Schaffer, C. B. Croft, and V. Solodushko Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1948 - H1954. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |